Senator wants FDA action on sunscreen ingredient
This article was originally published in The Tan Sheet
Executive Summary
Sen. Chuck Schumer, D-N.Y., urges FDA to evaluate data and offer consumer guidance on retinyl palmitate. He referenced preclinical data from the National Center for Toxicological Research and the National Toxicology Program that suggest an association between skin cancer and the compound. The vitamin A compound is found in 41 percent of sunscreens, according to the Environmental Working Group, which questioned the ingredient's use in its recent state-of-the-market sunscreen report (1"The Tan Sheet" June 7, 2010). EWG claims research available for nearly a year shows tumors and lesions developed up to 21 percent more rapidly in rodents coated with a retinyl-palmitate-based cream, versus animals in the non-RT group, when both groups were exposed to UV radiation. In his June 14 release, Schumer urges FDA to address concerns about retinyl palmitate and to announce a timeline for its long-delayed sunscreen final rule
You may also be interested in...
Dermatologists Find No Evidence That Vitamin A Sunscreens Cause Cancer
American Academy of Dermatology members say there is no evidence that the use of vitamin A in sunscreens causes cancer, contrary to a warning in the Environmental Working Group's latest sunscreen report
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.